AIMT - Aimmune Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $17.32. This is a potential upside of $17.32 (0%) from yesterday's end of day stock price of $0.

Aimmune Therapeutics's activity chart (see below) currently has 121 price targets and 100 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.39% with an average time for these price targets to be met of 119.43 days.

Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 01-Sep-2020. First documented stock forecast 31-Aug-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 19-Dec-2019

$18

5 years 7 months ago
(01-Sep-2020)

3/3 (100%)

$3.19 (21.54%)

78

Hold Since 31-Aug-2020

$60

5 years 7 months 1 days ago
(31-Aug-2020)

0/19 (0%)

$41.31 (221.03%)

Hold Since 31-Aug-2020

$34.5

$0.01 (0.03%)

$66

5 years 7 months 1 days ago
(31-Aug-2020)

1/9 (11.11%)

$0.28 (0.82%)

39

Hold Since 13-Dec-2019

$34.5

$0.01 (0.03%)

5 years 7 months 1 days ago
(31-Aug-2020)

5/5 (100%)

$0.28 (0.82%)

138

Hold Since 31-Aug-2020

$35

$0.51 (1.48%)

5 years 7 months 1 days ago
(31-Aug-2020)

5/14 (35.71%)

$0.78 (2.28%)

488

Show more analysts

Please expand the browser size to see the chart

What is AIMT (Aimmune Therapeutics) average time for price targets to be met?

On average it took 119.43 days on average for the stock forecasts to be realized with a an average price target met ratio 35.39

Which analyst has the current highest performing score on AIMT (Aimmune Therapeutics) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on AIMT (Aimmune Therapeutics)?

Charles Duncan has 11 price targets and 9 ratings on AIMT

Which analyst is the currently most bullish on AIMT (Aimmune Therapeutics)?

Jotin Marango with highest potential upside - $45.51

Which analyst is the currently most reserved on AIMT (Aimmune Therapeutics)?

Andrew Fein with lowest potential downside - -$19.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?